February 10, 2020

AMD AWARENESS

Exploring safety of stem cells for dry AMD Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy (GA), the advanced dry form of age-related macular degeneration (AMD). Read on ADVERTISEMENT

What non-retina specialists need to know about dry AMD A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry AMD–a leading cause of blindness among people 65 and older for which is there is no treatment–according to a report by a working group of scientists appointed by the National Advisory Eye Council (NAEC). Find out